Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-12

Clinical Trial Update: Effects of Dietary Flaxseed on Symptoms of Cardiovascular Disease in Patients With Peripheral Arterial Disease [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated the effect of dietary flaxseed on cardiovascular symptoms in patients with peripheral arterial disease; the study completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flaxseed (Linum usitatissimum seed)

Snippet

Sponsor: Dr. Grant Pierce | Conditions: Peripheral Arterial Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-12-12